Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
acute disseminated encephalomyelitis
acute necrotizing encephalitis
acyclovir
advances in neurology
adverse drug reaction
altered states of consciousness
alternative medicine
amyotrophic lateral sclerosis
anticonvulsants
antiviral agents
asymptomatic
attention span
autoimmune disease
behavior modification
behavioral disorder
bladder dysfunction
blood dyscrasias, neurologic findings with
brain biopsy
brain scan
breast feeding
calcification, intracranial
caloric testing
cancer, cerebrovascular accident complicating patients with
carcinoma
carcinoma of lung
cataracts, congenital
cerebral infarction, hemorrhagic
cerebral palsy
cerebral venous thrombosis
cerebral venous thrombosis, deep
cerebrospinal fluid, cytology
cerebrospinal fluid, gammaglobulin of
cerebrospinal fluid, xanthochromia of
cerebrovascular accident
cerebrovascular accident, rehabilitation of
cerebrovascular accident, thrombolytic agents in treatment
children
chills
chorioretinitis
cladribine
complementary medicine
compliance
complications
concentration, impaired
concussion
controversies in neurology
conversion reaction
cop 1
cost
cost effectiveness
cyst, porencephalic
cytomegalic inclusion disease
cytosine arabinoside
dementia
demyelinating disease
depression
depression, psychotic
dermatomyositis
diabetes mellitus
diagnostic criteria
disability rating scale, neurological
disability, neurological
dizziness
drug induced neurologic disorders
dural arteriovenous malformation
dural sinus thrombosis
efficacy
electroencephalogram
electron microscopy
electronystagmography
electronystagmography, abnormal
emotional lability
encephalitis
encephalitis, brainstem
encephalitis, clinical picture and treatment of
encephalitis, diagnosis of
encephalitis, viral
encephalitis, viral-causes of
epidemiology of neurology
episodic disorders
evidence-based research
extinction on double simultaneous stimulation
eye movement, disorders of
facial nerve palsy
facial weakness
fatigue
fever
fibrinolytic agents
fibrinolytic agents, complications
fibromyalgia
fingolimod
flu-like illness
gadolinium
gag reflex, depressed
gait disorder
gammaglobulin therapy, intravenous
glioblastoma multiforme(astrocytoma Gr.III)
Guillain Barre syndrome
head injury
headache
herpes labialis
herpes simplex encephalitis
herpes simplex encephalitis, differential diagnosis of
herpes simplex encephalitis, recurrent
herpes simplex encephalitis, treatment of
herpes simplex myelitis
herpes simplex virus
herpes simplex virus infection, immunosuppressed patient
herpes simplex virus, human nervous system and
herpes simplex virus, localization of
herpes simplex virus, malignancy with
herpes simplex virus, pathogenesis of
herpes simplex virus, pathology of
herpes simplex, neurocutaneous lesions in
herpes virus
herpes zoster
herpes, genital
hormone replacement
human herpesvirus 6
hydrocephalus
hypochondriasis
hypoglycorrhachia
iatrogenic neurologic disorders
imbalance
imbalance, postural
immunofluorescent exam of CSF cells
immunology and the nervous system
immunomodulation
immunosuppression
immunosuppressive agents
inclusion bodies, intranuclear
inclusion body myositis
infectious mononucleosis
interferon
interferon antibodies
interferon beta 1-a
interferon beta 1-b
interferon inducer
internet
intracerebral hemorrhage
intracranial pressure, increased
intrauterine infection, viral
intrauterine infection, viral of CNS
iododeoxyuridine
leukopenia
level of consciousness, decreased
limbic encephalitis
limbic system
liver function enzymes
lymphopenia
malformation, CNS, congenital
marihuana
medical-legal aspects of neurology
meningitis
meningitis, aseptic
mental status, abnormal
methotrexate
microcephaly
micropthalmia
mitoxantrone
monoamines
monoamines, brain
monoclonal antibodies
motor dysfunction
motor neuron disease
movement disorder
movement disorder, psychogenic
MRI
MRI, abnormal
MRI, ADC maps
MRI, contrast enhanced
MRI, demyelinating disease
MRI, diffusion weighted
MRI, early changes in CVA
MRI, incidental finding
MRI, serial
MRI, volumetry
multiple sclerosis
multiple sclerosis, acute
multiple sclerosis, asymptomatic
multiple sclerosis, diagnosis of
multiple sclerosis, disability status scale
multiple sclerosis, monosymptomatic
multiple sclerosis, prognosis
multiple sclerosis, radiologically isolated syndrome
multiple sclerosis, relapsing
multiple sclerosis, telling patient diagnosis of
multiple sclerosis, treatment of
muscle pain
muscular dystrophy
myasthenia gravis
myasthenia gravis, treatment of
myasthenic syndrome
myasthenic syndrome, treatment of
myelitis
myofascial pain syndrome
myopathy
natalizumab
neglect
neoplasm, primary intracerebral
neurologic complications of, systemic cancer
neurologic consultation
neurologic disease
neurologic disease, diagnoses of
neurologic disease, incurable
neurologic evaluation
neurologist
neuropathy
neuropathy, multifocal
neuropathy, peripheral, treatment
nystagmus
nystagmus, positional
ocular dysmetria
optic atrophy
optokinetic nystagmus(O.K.N.)
optokinetic nystagmus, abnormal
oral contraceptives
oral contraceptives, neurologic complications with
outcome research
oxybutynin
pathologic reflex
patient information and support
Persistent postural-perceptual dizziness
personality change
physician as patient
plasmapheresis
pleocytosis of cerebrospinal fluid
pneumonia
polyinosinic cytidic acid(poly IC)
polyneuropathy, chronic inflammatory demyelinating
practice guidelines
precipitating factors
pregnancy, neurologic complications in
pressure sores
prethrombotic state
primary intracranial hypotension
prognosis
progressive multifocal leucoencephalopathy
psychiatric disorder
psychiatric problems in neurologic disorders
psychomotor retardation
psychosis
pursuit eye movements
quality of life
rehabilitation for neurologic disorders
remote effect of cancer on the nervous system
review article
risk factors
rubella virus
saccadic eye movements
seizure
seizure, psychomotor-temporal lobe
seizure, treatment of
selective serotonin reuptake inhibitors
serologic testing
serotonin norepinephrine reuptake inhibitors
serum glutamic oxaloacetic transaminase
sexual dysfunction in neurologic disease
spasticity
spatial neglect
spinal cord
spinal cord, injury of
spinal cord, injury, complications with
spinal cord, injury, functional capacity of patient with
spinal cord, injury, prognosis in
spinal cord, injury, sexual dysfunction in
stem cell tourism
stem cell transplantation
steroid
steroid therapy, CNS treatment and complications with
stiff man syndrome
subacute myelo-opticoneuropathy(S.M.O.N.)complex
subspecialist
subtemporal decompression
systemic illness
talk
teleconsulting
telemedicine
teleneurology
telestroke
tender points
thoracic outlet syndromes
tissue plasminogen activator, intravenous
transplacental virus infections
trauma
treatment of neurologic disorder
trigeminal neuralgia
urinary tract infection
viral infection
viral infection, CNS
walking
weakness
workers' compensation
Showing articles 400 to 450 of 4627 << Previous Next >>

Severe Cardiac Failure in a Patient with Multiple Sclerosis Following Low-Dose Mitoxantrone Treatment
Neurol 73:991-993, D�rr,J.,et al, 2009

Pathologic and Immunologic Profiles of a Limited Form of Neuromyelitis Optica with Myelitis
Neurol 73:1628-1637, Yanagawa,K.,et al, 2009

Magnetic Resonance Imaging Predictors of Conversion to Multiple Sclerosis in the BENEFIT Study
Arch Neurol 66:1345-1352, Moraal,B.,et al, 2009

Reversible Cerebral Vasoconstriction Syndrome
Pract Neurol 9:256-267, Ducros,A. &Bousser,M.-G., 2009

Fully-Automated Quantification of Regional Brain Volumes for Improved Detection of Focal Atrophy in Alzheimers Disease
AJNR 30:578-580, Brewer, J.B.,et al, 2009

Tumefactive Demyelination: An Approach to Diagnosis and Management
JNNP 84:1047-1053, Hardy, T.A. & Chataway, J., 2009

"Cloud-like Enhancement" Is a Magnetic Resonance Imaging Abnormality Specific to Neuromyelitis Optica
Ann Neuro l 66:425-428, Ito, S.,et al, 2009

Oral Fingolimod (FTY720) in Multiple Sclerosis: Two-Year Results of a Phase II Extension Study
Neurol 72:73-79, OConnor,P.,et al, 2009

Relapse Management in Multiple Sclerosis
The Neurologist 15:1-5, Thrower,B.W., 2009

Opportunistic Infections and Other Risks with Newer Multiple Sclerosis Therapies
Ann Neurol 65:367-377, Berger,J.R. &Houff,S., 2009

Sustained-Release Oral Fampridine in Multiple Sclerosis: A Randomised, Double-Blind, Controlled Trial
Lancet 373:732-738, Goodman,A.D.,et al, 2009

NMO-IgG Detected in CSF in Seronegative Neuromyelitis Optica
Neurol 72:1101-1003, Klawiter,E.C.,et al, 2009

MRI in the Diagnosis of Pediatric Multiple Sclerosis
Neurol 72:961-967, Callen,D.J.A.,et al, 2009

Memantine Induces Reversible Neurologic Impairment in Patients with MS
Neurol 72:1630-1633, Villoslada,P.,et al, 2009

MRI Features of Benign Multiple Sclerosis: Toward a New Definition of This Disease Phenotype
Neurol 72:1693-1701, Rovaris,M.,et al, 2009

A Single, Early Magnetic Resonance Imaging Study in the Diagnosis of Multiple Sclerosis
Arch Neurol 66:587-592, Rovira,A.,et al, 2009

Diffusely Abnormal White Matter in Chronic Multiple Sclerosis: Imaging and Histopathologic Analysis
Arch Neurol 66:601-609, Seewann,A.,et al, 2009

Progressive Multifocal Leukoencephalopathy and Relapsing-Remitting Multiple Sclerosis: A Comparative Study
Arch Neurol 66:593-599, Boster,A.,et al, 2009

Early MRI in Optic Neuritis: The Risk for Disability
Neurol 72:542-550, Swanton,.K.,et al, 2009

Neuromyelitis Optica and Concentric Rings of Bal� in the Brainstem
Arch Neurol 66:274-275, Graber,J.J.,et al, 2009

Immunologic, Clinical, and Radiologic Status 14 Months After Cessation of Natalizumab Therapy
Neurol 72:396-401,392, Stuve,O.,et al, 2009

Posterior Reversible Encephalopathy Syndrome in Neuromyelitis Optica Spectrum Disorders
Neurol 72:712-717, Maga�a,S.M.,et al, 2009

Neurosarcoidosis: A Study of 30 New Cases
JNNP 80:297-304, Joseph,F.G. &Scolding,N.J., 2009

Pediatric Optic Neuritis: Brain MRI Abnormalities and Risk of Multiple Sclerosis
Neurol 72:881-885, Bonhomme,G.R.,et al, 2009

Hepatitis B Vaccine and the Risk of CNS Inflammatory Demyelination in Childhood
Neurol 72:873-880,870, Mikaeloff,Y.,et al, 2009

Clinicopath Conf, Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL)
NEJM 360:1656-1665, Case 12-2009, 2009

Human Natural Autoantibodies in the Treatment of Neurologic Disease
Neurol 72:1269-1276, Rodriguez,M.,et al, 2009

Cortical Lesions in Primary Progressive Multiple Sclerosis: A 2-Year Longitudinal MR Study
Neurol 72:1330-1336, Calabrese,M.,et al, 2009

Association Between Clinical Conversion to Multiple Sclerosis in Radiologically Isolated Syndrome and Magnetic Resonance Imaging, Cerebrospinal Fluid, and Visual Evoked Potential: Follow-Up of 70 Patients
Arch Neurol 66:841-846, Lebrun,C.,et al, 2009

Cyclophosphamide Therapy in Pediatric Multiple Sclerosis
Neurol 72:2076-2082,2064, Makhani,N.,et al, 2009

Efficacy of Treatment of MS with IFN B-1b or Glatiramer Acetate by Monthly Brain MRI in the BECOME Study
Neurol 72:1976-1983,1972, Cadavid,D.,et al, 2009

Exclusive Breastfeeding and the Risk of Postpartum Relapses in Women with Multiple Sclerosis
Arch Neurol 66:958-963, Langer-Gould,A.,et al, 2009

Smoking Is Associated with Increased Lesion Volumes and Brain Atrophy in Multiple Sclerosis
Neurol 73:504-510, Zivadinov,R.,et al, 2009

Deep Brain Stimulation for Tourette Syndrome
Neurol 73:e87-e90, Black,K., 2009

Real-Life Impact of Early Interferon� Therapy in Relapsing Multiple Sclerosis
Ann Neurol 66:513-520, Trojano,M.,et al, 2009

Primary Central Nervous System Lymphoma in a Patient Treated with Natalizumab
Ann Neurol 66:403-406, 261, 262, Schweikert,A.,et al, 2009

Natalizumab: A Double-Edged Sword?
Ann Neurol 66:262-263, DeAngelis,L., 2009

A 52-Year-Old Woman With Disabling Peripheral Neuropathy: Review of Diabetic Polyneuropathy
JAMA 302:1451-1458, Rutkove,S., 2009

Moderate Hypothermia to Treat Perinatal Asphyxial Encephalopathy
NEJM 361:1349-1358, Azzopardi,D.,et al, 2009

Nineteen Episodes of Recurrent Myelitis in a Woman with Neuromyelitis Optica and Systemic Lupus Erythematosus
Arch Neurol 66:1160-1163, Nasir, S.,et al, 2009

Treatment of Neuromyelitis Optica with Mycophenolate Mofetil
Arch Neurol 66:1128-1133, Jacob,A.,et al, 2009

Multiple Sclerosis with Predominant, Severe Cognitive Impairment
Arch Neurol 66:1139-1143, Staff,N.,et al, 2009

Progressive Multifocal Leukoencephalopathy After Natalizumab Monotherapy
NEJM 361:1081-1087, Linda,H.,et al, 2009

Asymptomatic Reactivation of JC Virus in Patients Treated with Natalizumab
NEJM 361:1067-1074, Chen,Y.,et al, 2009

Treatment of Progressive Multifocal Leukoencephalopathy Associated with Natalizumab
NEJM 361:1075-1080, Wenning,W.,et al, 2009

Reemergence of PML in Natalizumab-Treated Patients--New Cases, Same Concerns
NEJM 361:1041-1043, Major,E., 2009

Bal�s Disease Showing Benign Clinical Course and Co-Existence with Multiple Sclerosis-Like Lesions in Chinese
Multiple Sclerosis 14:418-424, Wang,C.,et al, 2008

Sporadic Adult-Onset Leukoencephalopathy with Neuroaxonal Spheroids Mimicking Cerebral MS
Neurol 70:1128-1133, Keegan,B.M.,et al, 2008

Picturing Multiple Sclerosis: Conventional and Diffusion Tensor Imaging
Semin Neurol 28:453-466, Fox,R.J., 2008

4-Aminopyridine Toxicity with Unintentional Overdose in Four Patients with Multiple Sclerosis
Neurol 71:1833-1834, Burton,J.M.,et al, 2008



Showing articles 400 to 450 of 4627 << Previous Next >>